|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
enhances neurogenesis in wild-type mice and in a mouse model of Alzheimers disease
,1
,1
,


,2
* The Shraga Segal Department of Microbiology and Immunology and
Ministry of Health, Mental Health Center, Anxiety and Stress Research Unit, Faculty of Health Sciences, and
The National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel; and
Medical Biotechnology Center, University of Southern Denmark, Odense, Denmark
2Correspondence: The Shraga Segal Dept. of Microbiology and Immunology, Faculty of Health Sciences, and The National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. E-mail: alonmon{at}bgu.ac.il
The generation of new neurons and glia from a precursor stem cell appears to take place in the adult brain. However, new neurons generated in the dentate gyrus decline sharply with age and to an even greater extent in neurodegenerative diseases. Here we raise the question whether peripheral immune mechanisms can generate immunity to such deficits in neuronal repair. We demonstrate that in contrast to primarily innate immunity cytokines, such as interleukin-6 and tumor necrosis factor-
, the adaptive immunity cytokine IFN-
enhances neurogenesis in the dentate gyrus of adult mice and improves the spatial learning and memory performance of the animals. In older mice, the effect of IFN-
is more pronounced in both wild-type mice and mice with Alzheimers-like disease and is associated with neuroprotection. In addition, IFN-
reverses the increase in oligodendrogenesis observed in a mouse model of Alzheimers disease. We demonstrate that limited amounts of IFN-
in the brain shape the neuropoietic milieu to enhance neurogenesis, possibly representing the normal function of the immune system in controlling brain inflammation and repair.—Baron, R., Nemirovsky, A., Harpaz, I., Cohen, H., Owens, T., Monsonego, A. IFN-
enhances neurogenesis in wild-type mice and in a mouse model of Alzheimers disease.
Key Words: cytokine immunity aging neurodegenerative disease neuronal repair
This article has been cited by other articles:
![]() |
V. W. Yong and S. Marks The interplay between the immune and central nervous systems in neuronal injury Neurology, January 5, 2010; 74(1_Supplement_1): S9 - S16. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mastrangelo, K. L. Sudol, W. C. Narrow, and W. J. Bowers Interferon-{gamma} Differentially Affects Alzheimer's Disease Pathologies and Induces Neurogenesis in Triple Transgenic-AD Mice Am. J. Pathol., November 1, 2009; 175(5): 2076 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Manczak, P. Mao, K. Nakamura, C. Bebbington, B. Park, and P. H. Reddy Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease Hum. Mol. Genet., October 15, 2009; 18(20): 3876 - 3893. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |